These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

291 related items for PubMed ID: 30557454

  • 1. The biomarker potential of cell-free microRNA from cerebrospinal fluid in Parkinsonian Syndromes.
    Starhof C, Hejl AM, Heegaard NHH, Carlsen AL, Burton M, Lilje B, Winge K.
    Mov Disord; 2019 Feb; 34(2):246-254. PubMed ID: 30557454
    [Abstract] [Full Text] [Related]

  • 2. MicroRNAs in Cerebrospinal Fluid as Potential Biomarkers for Parkinson's Disease and Multiple System Atrophy.
    Marques TM, Kuiperij HB, Bruinsma IB, van Rumund A, Aerts MB, Esselink RAJ, Bloem BR, Verbeek MM.
    Mol Neurobiol; 2017 Dec; 54(10):7736-7745. PubMed ID: 27844283
    [Abstract] [Full Text] [Related]

  • 3. Identification of plasma microRNA expression changes in multiple system atrophy and Parkinson's disease.
    Uwatoko H, Hama Y, Iwata IT, Shirai S, Matsushima M, Yabe I, Utsumi J, Sasaki H.
    Mol Brain; 2019 May 14; 12(1):49. PubMed ID: 31088501
    [Abstract] [Full Text] [Related]

  • 4. Exosomal miRNA as peripheral biomarkers in Parkinson's disease and progressive supranuclear palsy: A pilot study.
    Manna I, Quattrone A, De Benedittis S, Vescio B, Iaccino E, Quattrone A.
    Parkinsonism Relat Disord; 2021 Dec 14; 93():77-84. PubMed ID: 34839044
    [Abstract] [Full Text] [Related]

  • 5. CSF α-synuclein and UCH-L1 levels in Parkinson's disease and atypical parkinsonian disorders.
    Mondello S, Constantinescu R, Zetterberg H, Andreasson U, Holmberg B, Jeromin A.
    Parkinsonism Relat Disord; 2014 Apr 14; 20(4):382-7. PubMed ID: 24507721
    [Abstract] [Full Text] [Related]

  • 6. Serum miR-30c-5p is a potential biomarker for multiple system atrophy.
    Vallelunga A, Iannitti T, Dati G, Capece S, Maugeri M, Tocci E, Picillo M, Volpe G, Cozzolino A, Squillante M, Cicarelli G, Barone P, Pellecchia MT.
    Mol Biol Rep; 2019 Apr 14; 46(2):1661-1666. PubMed ID: 30810945
    [Abstract] [Full Text] [Related]

  • 7. Altered microRNA profiles in cerebrospinal fluid exosome in Parkinson disease and Alzheimer disease.
    Gui Y, Liu H, Zhang L, Lv W, Hu X.
    Oncotarget; 2015 Nov 10; 6(35):37043-53. PubMed ID: 26497684
    [Abstract] [Full Text] [Related]

  • 8. Plasma miR-34a-5p and miR-545-3p as Early Biomarkers of Alzheimer's Disease: Potential and Limitations.
    Cosín-Tomás M, Antonell A, Lladó A, Alcolea D, Fortea J, Ezquerra M, Lleó A, Martí MJ, Pallàs M, Sanchez-Valle R, Molinuevo JL, Sanfeliu C, Kaliman P.
    Mol Neurobiol; 2017 Sep 10; 54(7):5550-5562. PubMed ID: 27631879
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. MicroRNA Profile in Patients with Alzheimer's Disease: Analysis of miR-9-5p and miR-598 in Raw and Exosome Enriched Cerebrospinal Fluid Samples.
    Riancho J, Vázquez-Higuera JL, Pozueta A, Lage C, Kazimierczak M, Bravo M, Calero M, Gonalezález A, Rodríguez E, Lleó A, Sánchez-Juan P.
    J Alzheimers Dis; 2017 Sep 10; 57(2):483-491. PubMed ID: 28269782
    [Abstract] [Full Text] [Related]

  • 14. Differential expression and significance of miRNAs in plasma extracellular vesicles of patients with Parkinson's disease.
    Xie S, Niu W, Xu F, Wang Y, Hu S, Niu C.
    Int J Neurosci; 2022 Jul 10; 132(7):673-688. PubMed ID: 33045885
    [Abstract] [Full Text] [Related]

  • 15. Cerebrospinal fluid NFL in the differential diagnosis of parkinsonian disorders: A meta-analysis.
    Ge F, Ding J, Liu Y, Lin H, Chang T.
    Neurosci Lett; 2018 Oct 15; 685():35-41. PubMed ID: 30036569
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma miR-203a-3p as a Novel Predictor of Dementia in Patients with Parkinson's Disease.
    Hsu YF, Lin SP, Chu YT, Tsai YT, Huang JW, Phoa FKH, Wu RM.
    Int J Mol Sci; 2024 Mar 21; 25(6):. PubMed ID: 38542526
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cerebrospinal fluid levels of coenzyme Q10 are reduced in multiple system atrophy.
    Compta Y, Giraldo DM, Muñoz E, Antonelli F, Fernández M, Bravo P, Soto M, Cámara A, Torres F, Martí MJ, Catalan MSA Registry (CMSAR).
    Parkinsonism Relat Disord; 2018 Jan 21; 46():16-23. PubMed ID: 29107645
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.